about
Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.Influence of two different resection techniques (conventional liver resection versus anterior approach) of liver metastases from colorectal cancer on hematogenous tumor cell dissemination - prospective randomized multicenter trialGenome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial.Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients.Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133(+) human colorectal cancer cells.Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma.Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma.The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma riskRegulation of angiogenesis by oxygen and metabolism.Meta-analysis of standard, restrictive and supplemental fluid administration in colorectal surgery.Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases.TAM receptors Tyro3 and Mer as novel targets in colorectal cancer.Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands.Angiogenesis: a target in solid tumors, also in leukemia?Human mesenchymal stem cells enhance the systemic effects of radiotherapy.Value of functional imaging by PET in esophageal cancer.Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis.The postoperative part of perioperative chemotherapy fails to provide a survival benefit in completely resected esophagogastric adenocarcinoma.Gastric Preconditioning in Advance of Esophageal Resection-Systematic Review and Meta-Analysis.Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemia.YAP/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis.Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection.Protein Profiling Gastric Cancer and Neighboring Control Tissues Using High-Content Antibody Microarrays.Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma.Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer.Influence of age on resection of colorectal liver metastases.Angiogenic and growth factors in gastric cancer.Serum microRNA profiles as prognostic or predictive markers in the multimodality treatment of patients with gastric cancer.Pharmacological HIF-inhibition attenuates postoperative adhesion formationMalignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6.Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapy.Infrahepatic inferior vena cava clamping for reduction of central venous pressure and blood loss during hepatic resection: a randomized controlled trial.VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma.Sphincter-Preserving Surgery for Low Rectal Cancer: Do We Overshoot the Mark?Significant decrease of mortality due to anastomotic leaks following esophageal resection: management makes the difference.Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?A novel pretherapeutic gene expression-based risk score for treatment guidance in gastric cancer.Prolyl Hydroxylase Inhibition Enhances Liver Regeneration Without Induction of Tumor Growth.
P50
Q30579125-34C7FD21-6BA3-42E6-BE5C-CD11A8A8B263Q33322607-D4BC9FF4-9EBB-4A92-9AA9-FC2BBD041615Q34537405-78860461-80CF-4869-AE2F-4BAD33D3AB2FQ35798947-34F90BEF-88D9-4295-B18E-B7C96765944AQ36081008-EBA32610-11E3-4660-99AB-98C46880F1F6Q36195433-FE1CDBB8-D0F0-42A0-8444-B17DEF168DA7Q36358569-8BE5DF4E-3D45-47A2-BE1A-2F646B4622DFQ36655904-47C76151-50D1-436D-94A5-79F828137CD0Q36895095-6B5B0E80-277D-4B32-A78B-59D65FE5DFE1Q37393186-D7015EAC-40CA-4977-8221-F813CD8AEE56Q37414130-B5B7446A-7902-4E42-9E57-9776F1C0428FQ37507440-3BB799CA-F936-49DF-8785-0208AB4C9EF2Q37636630-4ECFDDF8-F649-4F27-AF44-40AF662AA45EQ37955105-5F88CBBC-D5B9-438B-8293-6B94C969442BQ37967243-0F8A6564-B79D-4484-8741-ED2883D923E1Q38260564-66E9CABF-D5F4-4C4F-B03D-B6EB2E062749Q38359635-BABF4DB5-6F64-4975-921F-64C12733A3ECQ38663129-E9AA0047-37FF-443D-9D83-2CF47C2395DBQ38690480-5F6B0A08-7483-42C4-9AA6-B7A797C0189CQ39260430-9192F837-DCD4-4BC9-808E-07E13F6D07C6Q39526312-051B2E35-FE88-475C-802D-1A9799F1B67CQ40501965-D8197C56-6380-460E-B872-D8F3BEE47EE9Q40693739-D3838FDC-9121-45AA-AF3B-5FA25AE69AD8Q41213418-2E9A5874-AB3B-417E-9FCB-072D317F8591Q41215316-BE9A65B6-3C18-4F7C-ACDA-88E12841E5AEQ41454619-3B151A26-BD4C-4A1E-AE69-0D6A8B24394DQ41471150-12650D94-6BD6-479D-ABA6-B999B9657F02Q41568967-04CC273F-D890-44F2-B576-90792BAF12AFQ41597172-729D2AF7-3363-4C0C-BC1D-7459A538F75BQ41991058-119DC80D-012A-419E-B783-D4F908122A37Q42377201-D410B7D6-2C26-47FB-AABC-42DA850E94FCQ43228829-24684017-E3D9-458B-9008-F421953E3C08Q44399864-9B1B16E1-02E6-4561-B746-CCE1615FE89DQ45184631-CC9F98CF-C7C9-4A3A-9332-75FA3D936C3CQ46202577-98021BCE-8921-4942-93F5-69DA5E80789CQ47604360-D349570B-844F-4445-A5CE-A3788D323765Q47870015-4863CEC6-E3FB-4C4B-A139-1FCAB499DFD6Q48163558-3DC2DD1B-4CEF-4557-BCBA-66280595585FQ50082507-A770C707-BC35-4FE3-B84A-073EA50E78D2Q50680919-0F5C426F-A318-48AC-8978-3B1C48BBD160
P50
description
onderzoeker
@nl
researcher ORCID: 0000-0002-7166-3675
@en
name
Thomas Schmidt
@ast
Thomas Schmidt
@en
Thomas Schmidt
@es
Thomas Schmidt
@sl
type
label
Thomas Schmidt
@ast
Thomas Schmidt
@en
Thomas Schmidt
@es
Thomas Schmidt
@sl
prefLabel
Thomas Schmidt
@ast
Thomas Schmidt
@en
Thomas Schmidt
@es
Thomas Schmidt
@sl
P214
P106
P21
P214
P31
P496
0000-0002-7166-3675
P734
P735
P7859
viaf-28229172